Colton Groome Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-350
Closed -$273K 138
2025
Q2
$273K Sell
350
-50
-13% -$38.9K 0.09% 112
2025
Q1
$360K Sell
400
-40
-9% -$33.3K 0.14% 88
2024
Q4
$340K Sell
440
-32
-7% -$26.5K 0.13% 86
2024
Q3
$418K Sell
472
-45
-9% -$40.5K 0.16% 86
2024
Q2
$468K Buy
+517
New +$414K 0.18% 70

Other funds holding LLY

Colton Groome Financial Advisors's LLY Position: Q3 2025 in Review

Colton Groome Financial Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 350 shares — an estimated $273K sold.

Colton Groome Financial Advisors first reported a position in LLY in Q2 2024 and held it in 5 quarters. The position peaked at $468K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Colton Groome Financial Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Colton Groome Financial Advisors sold 350 Eli Lilly shares in Q3 2025, an estimated $273K.
  • Colton Groome Financial Advisors first reported a position in Eli Lilly in Q2 2024 and held it in 5 quarters.
  • Colton Groome Financial Advisors's Eli Lilly position peaked at $468K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Colton Groome Financial Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.